Bristol-Myers Squibb Names Elliott Sigal to Board of Directors

Bristol-Myers Squibb Company BMY today announced that Elliott Sigal, M.D., Ph.D., has been elected to its Board of Directors, effective today. Dr. Sigal also will be a member of the Board's Science and Technology Committee.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsManagementHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!